Timothy D. McClure, MD

Timothy D. McClure, MD, is an assistant professor of urology at Weill Cornell Medical College in New York, New York.

Articles by Timothy D. McClure, MD

Timothy McClure, MD, on next steps for focal therapy in prostate cancer

August 27th 2025

Timothy D. McClure, MD, offers his thoughts on how future advancements will inform the role for focal therapy in prostate cancer.

Timothy McClure, MD, highlights data on IRE for prostate tissue ablation

ByTimothy D. McClure, MD

August 18th 2025

Timothy D. McClure, MD, outlines key findings from the PRESERVE trial, which evaluated IRE for prostate tissue ablation in patients with intermediate-risk prostate cancer.

Timothy McClure, MD, on patient selection for focal therapy

ByTimothy D. McClure, MD

August 13th 2025

Timothy D. McClure outlines his approach to patient selection with focal therapy as well as how NanoKnife fits into that landscape.

Timothy McClure, MD, discusses focal therapy with irreversible electroporation

ByTimothy D. McClure, MD

August 8th 2025

Timothy D. McClure, MD, discusses focal therapy with IRE, specifically highlighting its benefits and limitations compared with other treatment options.

Timothy D. McClure, MD

Articles by Timothy D. McClure, MD

Timothy McClure, MD, on next steps for focal therapy in prostate cancer

Timothy McClure, MD, highlights data on IRE for prostate tissue ablation

Timothy McClure, MD, on patient selection for focal therapy

Timothy McClure, MD, discusses focal therapy with irreversible electroporation

Latest Updated Articles

Trending on Urology Times

FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures

Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC

Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study

BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC

Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer